← Back to Team

Houman Ashrafian

Scientific Advisor

Houmana banner

During his time as a Partner then Managing Partner as SV 2016-2023, Houman co-founded seven SV companies. He currently serves as Executive Vice President, Head of Research and Development at Sanofi.

Previously, Houman co-founded the services company Cardiac Report in 2003, as well as Heart Metabolics in 2008. Heart Metabolics successfully repositioned perhexiline, as a treatment for hypertrophic cardiomyopathy and heart failure. Perhexiline is now in advanced clinical trials and has orphan drug designation. He went on to become Vice President and head of the Clinical Science Group at UCB Pharma.

Outside of SV, following completion of his cardiology training, Houman was appointed as an Honorary Consultant Cardiologist in 2011 at the John Radcliffe Hospital in Oxford. Additionally, Houman co-founded Weatherden, a boutique clinical development company.

Academic credentials

Undergraduate degree, University of Cambridge; BM BCh, DPhil, University of Oxford.

Investing in Women Code Logo

We invest in talented innovators. We strongly adhere to the view that diversity, including under-represented groups, strongly adds to success. If you are an entrepreneur seeking investment and a partner who can help you to build your business, we would love to hear from you. Please get in contact with our team.